InMed Pharmaceuticals Inc. (INM) stock
INMNasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as MTRI
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 3, 2026Score 4/30
$1.37+0.05 (+3.44%)
Close on Oct 19, 2026Market cap $83.97MP/E –Yield –
InMed Pharmaceuticals price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
InMed Pharmaceuticals's price to sales ratio was 0.4× on Apr 30, 2026, against 0.4× a year earlier. Over the last 4 years it ranged from 0.2× to 9.3×, with a median of 0.6×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Apr 30, 2026 | 0.4× | −0.1 |
| 2025 | Dec 31, 2025 | 0.6× | −0.1 |
| 2024 | Dec 31, 2024 | 0.6× | +0.3 |
| 2023 | Dec 29, 2023 | 0.3× | −1.0 |
| 2022 | Dec 30, 2022 | 1.3× | −5.1 |
| 2021 | Oct 29, 2021 | 6.4× | – |
See a number that looks wrong?